Company profile EVOK

Evoke Pharma Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 22:38:42.

After 39 days of this quarter the interest is at 8.0. Based on that we can calculate that during remaining 52 days it will total up to 19.0.
Evoke Pharma expected interest is significantly lower compared to previous quarter (-66.1%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2019103
66
-35.9% QoQ
133
101.5% QoQ
30
-77.4% QoQ
2020 32
-68.9% YoY 6.7% QoQ
233
253.0% YoY 628.1% QoQ
206
54.9% YoY -11.6% QoQ
143
376.7% YoY -30.6% QoQ
2021 167
421.9% YoY 16.8% QoQ
151
-35.2% YoY -9.6% QoQ
87
-57.8% YoY -42.4% QoQ
112
-21.7% YoY 28.7% QoQ
2022 75
-55.1% YoY -33.0% QoQ
82
-45.7% YoY 9.3% QoQ
56
-35.6% YoY -31.7% QoQ
38
-66.1% YoY -32.1% QoQ
2023 30
-60.0% YoY -21.1% QoQ
45
-45.1% YoY 50.0% QoQ
77
37.5% YoY 71.1% QoQ
56
47.4% YoY -27.3% QoQ
2024 8
-73.3% YoY -85.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Evoke Pharma search interestLast update: February 08 2024 22:38:41.
Correlation coefficient between keyword and revenue is -0.65
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:38:46.

The average 5 years interest of Evoke Pharma was 7.39 per week.
The last year interest of Evoke Pharma compared to the last 5 years has changed by -45.6%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -40.62%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 22:39:00.

After 39 days of this quarter the interest is at 116.0. Based on that we can calculate that during remaining 52 days it will total up to 271.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019138
58
-58.0% QoQ
94
62.1% QoQ
121
28.7% QoQ
2020 55
-60.1% YoY -54.5% QoQ
229
294.8% YoY 316.4% QoQ
133
41.5% YoY -41.9% QoQ
160
32.2% YoY 20.3% QoQ
2021 89
61.8% YoY -44.4% QoQ
99
-56.8% YoY 11.2% QoQ
116
-12.8% YoY 17.2% QoQ
48
-70.0% YoY -58.6% QoQ
2022 165
85.4% YoY 243.8% QoQ
188
89.9% YoY 13.9% QoQ
131
12.9% YoY -30.3% QoQ
163
239.6% YoY 24.4% QoQ
2023 259
57.0% YoY 58.9% QoQ
286
52.1% YoY 10.4% QoQ
204
55.7% YoY -28.7% QoQ
214
31.3% YoY 4.9% QoQ
2024 116
-55.2% YoY -45.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Gimoti search interestLast update: February 08 2024 22:38:58.
Correlation coefficient between keyword and revenue is 0.5
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:39:01.

The average 5 years interest of Gimoti was 11.75 per week.
The last year interest of Gimoti compared to the last 5 years has changed by 65.28%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 126.34%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Metoclopramide nasal spray to provide analysis

Correlation between past revenue and Metoclopramide nasal spray search interest

There is not enough data for Metoclopramide nasal spray to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Metoclopramide nasal spray to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Acute gastroparesis treatment to provide analysis

Correlation between past revenue and Acute gastroparesis treatment search interest

There is not enough data for Acute gastroparesis treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Acute gastroparesis treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Recurrent gastroparesis treatment to provide analysis

Correlation between past revenue and Recurrent gastroparesis treatment search interest

There is not enough data for Recurrent gastroparesis treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Recurrent gastroparesis treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evoke Pharma jobs to provide analysis

Correlation between past revenue and Evoke Pharma jobs search interest

There is not enough data for Evoke Pharma jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evoke Pharma jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evoke Pharma reviews to provide analysis

Correlation between past revenue and Evoke Pharma reviews search interest

There is not enough data for Evoke Pharma reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evoke Pharma reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Solana Beach healthcare to provide analysis

Correlation between past revenue and Solana Beach healthcare search interest

There is not enough data for Solana Beach healthcare to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Solana Beach healthcare to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evoke Pharma -stock -company to provide analysis

Correlation between past revenue and Evoke Pharma -stock -company search interest

There is not enough data for Evoke Pharma -stock -company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evoke Pharma -stock -company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for EVOK
Earnings date: 2024-03-06 After close
Company name: Evoke Pharma Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-02-09T05:00:00.000Z

US FDA
Approval of Gimoti, Nda #209388 (Labeling)

2025-12-17T10:50:00-05:00

PR Newswire
Evoke Pharma and QOL Medical Announce Expiration of Tender Offer

2025-11-18T12:20:00-05:00

PR Newswire
Halper Sadeh LLC Encourages AXTA, COMP, EVOK, JTAI Shareholders to Contact the Firm to Discuss Their Rights

2025-11-17T20:30:00-05:00

PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-COMP, HFWA, EVOK, and JTAI

2025-11-13T17:30:00-05:00

PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-HBAN, AVDL, EVOK, and TRUE

2025-11-13T12:00:00Z

GlobeNewswire
Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update

2025-11-05T12:40:00-05:00

PR Newswire
Halper Sadeh LLC Encourages HBAN, FFWM, EVOK Shareholders to Contact the Firm to Discuss Their Rights

2025-11-04T11:28:00-05:00

PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders

2025-11-04T12:00:00Z

GlobeNewswire
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical

2025-09-08T16:33:20-04:00

SEC
SCHEDULE 13G Form - Statement of Beneficial Ownership by Certain Investors - Evoke Pharma Inc (0001403708) (Subject)

2025-08-26T11:00:27Z

GlobeNewswire
Evoke Pharma and EVERSANA Expand GIMOTIĀ® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship

2025-08-21T11:00:11Z

GlobeNewswire
Evoke Pharma Announces Listing of New GIMOTIĀ® Patent in FDA Orange Book

2025-08-14T11:00:49Z

GlobeNewswire
Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update

2025-08-06T10:30:31Z

GlobeNewswire
Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038

2025-08-06T06:30:26-04:00

SEC
8-K Form - Current report, item 8.01 - Evoke Pharma Inc (0001403708) (Filer)